Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China.

Pingzheng Mo,Yuanyuan Xing,Yu Xiao,Liping Deng,Qiu Zhao,Hongling Wang,Yong Xiong,Zhenshun Cheng,Shicheng Gao,Ke Liang,Mingqi Luo,Tielong Chen,Shihui Song,Zhiyong Ma,Xiaoping Chen,Ruiying Zheng,Qian Cao,Fan Wang,Yongxi Zhang
DOI: https://doi.org/10.1093/cid/ciaa270
IF: 20.999
2020-01-01
Clinical Infectious Diseases
Abstract:Background Since December 2019, novel coronavirus (SARS-CoV-2)-infected pneumonia (COVID-19) occurred in Wuhan, and rapidly spread throughout China. This study aimed to clarify the characteristics of patients with refractory COVID-19. Methods In this retrospective single-center study, we included 155 consecutive patients with confirmed COVID-19 in Zhongnan Hospital of Wuhan University from January 1st to February 5th. The cases were divided into general and refractory COVID-19 groups according to the clinical efficacy after hospitalization, and the difference between groups were compared. Results Compared with general COVID-19 patients (45.2%), refractory patients had an older age, male sex, more underlying comorbidities, lower incidence of fever, higher levels of maximum temperature among fever cases, higher incidence of breath shortness and anorexia, severer disease assessment on admission, high levels of neutrophil, aspartate aminotransferase (AST), lactate dehydrogenase (LDH) and C-reactive protein, lower levels of platelets and albumin, and higher incidence of bilateral pneumonia and pleural effusion (P Conclusion Nearly 50% COVID-19 patients could not reach obvious clinical and radiological remission within 10 days after hospitalization. The patients with male sex, anorexia and no fever on admission predicted poor efficacy.
What problem does this paper attempt to address?